Sof foyda bo'yicha sotuv rentabelligi: Aadi Bioscience Inc (WHWK)

Aadi Bioscience, Inc. (WHWK) grafik logotipi

Aadi Bioscience Inc (WHWK) onkologik dori vositalarining tarqatilishini kengaytirmoqda va shu bilan birga tadqiqot va ishlanmalar (R&D) xarajatlarini optimallashtirmoqda. GURU.Markets tahlillari ushbu grafikni taqdim etadi, unda sof foyda marjasi mahalliy dinamikani namoyish etadi va 0.00 qiymati joriy ko'rsatkich vazifasini o'taydi. Daromadlar noyob o'smalarni davolash uchun FYARRO sotuviga asoslangan. Albumin asosidagi dori yetkazib berish tizimlarini ishlab chiqishga muhandislik yondashuvi terapiya aniqligini sezilarli darajada oshiradi.

aadibio.com (WHWK) - Sof marja 20.03.2025dan 19.11.2026gacha

Aadi Bioscience Inc kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:aadibio.com - WHWK
aadibio.com ishlab chiqargan mahsulot

Aadi Bioscience Inc (WHWK) tor doiradagi onkologik dori vositalarini ishlab chiqishga ixtisoslashgan. Sof foyda marjasi barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyin qolgan daromad qismini belgilaydi. Ushbu ko'rsatkich intellektual mulkni monetizatsiya qilishning haqiqiy samaradorligini o'lchaydi. Bir nechta mahsulotlarning muvaffaqiyatiga bog'liq bo'lgan kompaniya uchun sof foyda marjasining har qanday pasayishi litsenziyalash risklaridan dalolat beradi. Ushbu kunlik grafik hisobot vaqtidagi kechikishlarni bartaraf etib, kapitalning aniq bahosini taqdim etadi.

Asosiy raqobatchilar

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)